# Vitamin D to Resolve Inflammation After Tuberculosis (ResolveD-TB)

> **NCT03011580** · PHASE2 · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 15 (actual)

## Conditions studied

- Recurrent Tuberculosis

## Interventions

- **DIETARY_SUPPLEMENT:** Fultium-D3
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03011580
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-14
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011580, "Vitamin D to Resolve Inflammation After Tuberculosis (ResolveD-TB)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03011580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*